Characterisation of RA patients not requiring retreatment with rituximab within 12 months after the first course. A CERERRA study

R.F. Van Vollenhoven, Chatzidionysiou, E. Nasonov, G. Lukina, Merete Lund Hetland, Ulrik Tarp, C. Gabay, P.P.L.C. van Riel, D.C. Nordström, J. Gomez-Reino, K. Pavelka, M. Tomsic, E. Lie, T.K. Kvien

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
ISSN0003-4967
Publication statusPublished - 2010

Cite this